Glycyx Therapeutics
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase II Trial for MOR Antagonism With Axelopran to Enhance Immunotherapy in Head and Neck Cancer (NCT07662720) | Glycyx Therapeutics | 2026-07-15 |
Track Glycyx Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.